☰

Prem K. Premsrirut, Ph.D. - Publications

Affiliations: 
2010 Genetics Stony Brook University, Stony Brook, NY, United States 
Area:
Genetics, Oncology, Molecular Biology
Tree Info Grants Similar researchers PubMed Report error

25 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2018 Premsrirut PK, Wang C, Yang Y, Dow LE, Zuber J, Lowe SW. Abstract 5106: CRISPR/Cas9-based development of RNAi rat models for drug discovery Cancer Research. 78: 5106-5106. DOI: 10.1158/1538-7445.Am2018-5106  0.473
2017 Pelossof R, Fairchild L, Huang CH, Widmer C, Sreedharan VT, Sinha N, Lai DY, Guan Y, Premsrirut PK, Tschaharganeh DF, Hoffmann T, Thapar V, Xiang Q, Garippa RJ, Rätsch G, et al. Prediction of potent shRNAs with a sequential classification algorithm. Nature Biotechnology. PMID 28263295 DOI: 10.1038/Nbt.3807  0.505
2017 Wolter K, Pesic M, Klotz S, Herranz N, Wuestefeld T, Kang T, Seehawer M, Chawla R, Zwirner S, Cotton J, Zhou B, Krüger M, Klawonn F, Longerich T, Sipos B, ... ... Premsrirut PK, et al. Abstract LB-335: Induction of Ribosomal Checkpoint Induced Senescence (RCIS) for the treatment of liver cancer Cancer Research. 77. DOI: 10.1158/1538-7445.Am2017-Lb-335  0.479
2016 Premsrirut P, Martin G, Dow L, Kim S, Zuber J, Hannon G, Lowe S. RNAi and CRISPR/Cas9 based in vivo models for drug discovery European Journal of Cancer. 61: S208. DOI: 10.1182/Blood.V130.Suppl_1.5568.5568  0.605
2016 Premsrirut PK, Martin G, Dow L, Kim SY, Zuber J, Lowe S, Hannon G. Abstract 4188: RNAi and CRISPR/Cas9 basedin vivomodels for drug discovery Cancer Research. 76: 4188-4188. DOI: 10.1158/1538-7445.Am2016-4188  0.48
2015 Mullenders J, Aranda-Orgilles B, Lhoumaud P, Keller M, Pae J, Wang K, Kayembe C, Rocha PP, Raviram R, Gong Y, Premsrirut PK, Tsirigos A, Bonneau R, Skok JA, Cimmino L, et al. Cohesin loss alters adult hematopoietic stem cell homeostasis, leading to myeloproliferative neoplasms. The Journal of Experimental Medicine. PMID 26438359 DOI: 10.1084/Jem.20151323  0.304
2015 Li X, Chuang PY, D'Agati VD, Dai Y, Yacoub R, Fu J, Xu J, Taku O, Premsrirut PK, Holzman LB, He JC. Nephrin Preserves Podocyte Viability and Glomerular Structure and Function in Adult Kidneys. Journal of the American Society of Nephrology : Jasn. PMID 25644109 DOI: 10.1681/Asn.2014040405  0.416
2015 Premsrirut PK, Wang C, Yang Y, Pelossof R, Leslie C, Fellmann C, Dow L, Zuber J, Lowe S. Abstract B37: RNAi and CRISPR/Cas9-based in vivo models for drug discovery Cancer Research. 78: 4188-4188. DOI: 10.1158/1538-7445.Mousemodels17-B37  0.657
2015 Premsrirut PK, Fellmann C. Abstract LB-078: RNAi and CRISPR/Cas9-based in vivo models for drug discovery Molecular and Cellular Biology. DOI: 10.1158/1538-7445.Am2015-Lb-078  0.384
2014 Chuang PY, Xu J, Dai Y, Jia F, Mallipattu SK, Yacoub R, Gu L, Premsrirut PK, He JC. In vivo RNA interference models of inducible and reversible Sirt1 knockdown in kidney cells. The American Journal of Pathology. 184: 1940-56. PMID 24952428 DOI: 10.1016/J.Ajpath.2014.03.016  0.429
2014 Miething C, Scuoppo C, Bosbach B, Appelmann I, Nakitandwe J, Ma J, Wu G, Lintault L, Auer M, Premsrirut PK, Teruya-Feldstein J, Hicks J, Benveniste H, Speicher MR, Downing JR, et al. PTEN action in leukaemia dictated by the tissue microenvironment. Nature. 510: 402-6. PMID 24805236 DOI: 10.1038/Nature13239  0.513
2014 Premsrirut P, Dow L, Hannon G, Zuber J, Lowe S, Zender L, Fellmann C. Abstract PR07: RNAi mouse models: Revolutionizing drug discovery in vivo Molecular Cancer Research. 12. DOI: 10.1158/1557-3125.Modorg-Pr07  0.708
2014 Sridhar V, Lai DY, Sinha N, Premsrirut PK, Fellmann C. Abstract LB-319: Functionally validated shRNA libraries for large-scale RNAi screens Cancer Research. 74. DOI: 10.1158/1538-7445.Am2014-Lb-319  0.467
2014 Premsrirut PK, Yoon B, Pesic M, Dow LE, Zuber J, Lowe SW, Hannon GJ, Zender L, Fellmann C. Abstract 2974: RNAi mouse models: Revolutionizing drug discovery in vivo Cancer Research. 74: 2974-2974. DOI: 10.1158/1538-7445.Am2014-2974  0.643
2014 Wuestefeld T, Pesic M, Kang T, Malek N, Premsrirut P, Lowe S, Zender L. Development of shRNA transgenic mice for preclinical studies of the MKK4 regeneration kinase Zeitschrift FüR Gastroenterologie. 52. DOI: 10.1055/s-0033-1360855  0.502
2013 Premsrirut PK, Dow LE, Park Y, Hannon GJ, Lowe SW. Creating transgenic shRNA mice by recombinase-mediated cassette exchange Cold Spring Harbor Protocols. 2013: 835-842. PMID 24003198 DOI: 10.1101/Pdb.Prot077057  0.628
2012 Lin CJ, Nasr Z, Premsrirut PK, Porco JA, Hippo Y, Lowe SW, Pelletier J. Targeting synthetic lethal interactions between Myc and the eIF4F complex impedes tumorigenesis. Cell Reports. 1: 325-33. PMID 22573234 DOI: 10.1016/J.Celrep.2012.02.010  0.516
2012 Dow LE, Premsrirut PK, Zuber J, Fellmann C, McJunkin K, Miething C, Park Y, Dickins RA, Hannon GJ, Lowe SW. A pipeline for the generation of shRNA transgenic mice Nature Protocols. 7: 374-393. PMID 22301776 DOI: 10.1038/Nprot.2011.446  0.659
2012 Premsrirut P, Fellmann C, Dow L, Lowe S, Zuber J, Hannon G. 45 Next Generation RNAi Mouse Models for Drug Discovery and Toxicology Assessment European Journal of Cancer. 48: 16. DOI: 10.1016/S0959-8049(12)71843-9  0.467
2012 Premsrirut P, Fellmann C, Hannon G, Lowe S, Zuber J, Elledge S. 58 Proffered Paper: Next Generation RNAi Mouse Models for Drug Discovery and Toxicology Assessment European Journal of Cancer. 48: S14. DOI: 10.1016/S0959-8049(12)70762-1  0.46
2011 Chien Y, Scuoppo C, Wang X, Fang X, Balgley B, Bolden JE, Premsrirut P, Luo W, Chicas A, Lee CS, Kogan SC, Lowe SW. Control of the senescence-associated secretory phenotype by NF-κB promotes senescence and enhances chemosensitivity. Genes & Development. 25: 2125-36. PMID 21979375 DOI: 10.1101/Gad.17276711  0.496
2011 McJunkin K, Mazurek A, Premsrirut PK, Zuber J, Dow LE, Simon J, Stillman B, Lowe SW. Reversible suppression of an essential gene in adult mice using transgenic RNA interference. Proceedings of the National Academy of Sciences of the United States of America. 108: 7113-8. PMID 21482754 DOI: 10.1073/Pnas.1104097108  0.671
2011 Premsrirut PK, Dow LE, Kim SY, Camiolo M, Malone CD, Miething C, Scuoppo C, Zuber J, Dickins RA, Kogan SC, Shroyer KR, Sordella R, Hannon GJ, Lowe SW. A rapid and scalable system for studying gene function in mice using conditional RNA interference Cell. 145: 145-158. PMID 21458673 DOI: 10.1016/J.Cell.2011.03.012  0.668
2010 Takiguchi M, James C, Josefsson EC, Carmichael CL, Premsrirut PK, Lowe SW, Hamilton JR, Huang DC, Kile BT, Dickins RA. Transgenic, inducible RNAi in megakaryocytes and platelets in mice. Journal of Thrombosis and Haemostasis : Jth. 8: 2751-6. PMID 21138522 DOI: 10.1111/J.1538-7836.2010.04077.X  0.641
2007 Dickins RA, McJunkin K, Hernando E, Premsrirut PK, Krizhanovsky V, Burgess DJ, Kim SY, Cordon-Cardo C, Zender L, Hannon GJ, Lowe SW. Tissue-specific and reversible RNA interference in transgenic mice. Nature Genetics. 39: 914-21. PMID 17572676 DOI: 10.1038/Ng2045  0.682
Show low-probability matches.